Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Botulinum Neurotoxins Market Report 2016

  • QYR698713
  • 117 Pages
  • October 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Botulinum Neurotoxins

Revenue, means the sales value of Botulinum Neurotoxins

This report studies sales (consumption) of Botulinum Neurotoxins in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Johnson & Johnson

GSK

Allergan

Chong Kun Dang

Eisai

Nestle

Galderma

Ipsen

Hugel

Mentor

CROMA

Alphaeon

OBI Pharma

Revance Therapeutics

Daewoong Pharmaceutical

Medy-Tox

EpiVax

Anterios

Escape Therapeutics

Lipella

Malvern Cosmeceutics

PharmaVital

Merz Pharma

Transdermal

Valeant Pharmaceuticals

CNBG

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Botulinum Neurotoxins A (BoNT/A)

Botulinum Neurotoxins B (BoNT/B)

Botulinum Neurotoxins E (BoNT/E)

Botulinum Neurotoxins F (BoNT/F)

Botulinum Neurotoxins C (BoNT/C)

Botulinum Neurotoxins D (BoNT/D)

Botulinum Neurotoxins G (BoNT/G)

Split by applications, this report focuses on sales, market share and growth rate of Botulinum Neurotoxins in each application, can be divided into

Medical Uses

Cosmetics

Application 3

Table of Contents

United States Botulinum Neurotoxins Market Report 2016

1 Botulinum Neurotoxins Overview

1.1 Product Overview and Scope of Botulinum Neurotoxins

1.2 Classification of Botulinum Neurotoxins

1.2.1 Botulinum Neurotoxins A (BoNT/A)

1.2.2 Botulinum Neurotoxins B (BoNT/B)

1.2.3 Botulinum Neurotoxins E (BoNT/E)

1.2.4 Botulinum Neurotoxins F (BoNT/F)

1.2.5 Botulinum Neurotoxins C (BoNT/C)

1.2.6 Botulinum Neurotoxins D (BoNT/D)

1.2.7 Botulinum Neurotoxins G (BoNT/G)

1.3 Application of Botulinum Neurotoxins

1.3.1 Medical Uses

1.3.2 Cosmetics

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Botulinum Neurotoxins (2011-2021)

1.4.1 USA Botulinum Neurotoxins Sales and Growth Rate (2011-2021)

1.4.2 USA Botulinum Neurotoxins Revenue and Growth Rate (2011-2021)

2 USA Botulinum Neurotoxins Competition by Manufacturers

2.1 USA Botulinum Neurotoxins Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Botulinum Neurotoxins Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Botulinum Neurotoxins Average Price by Manufactures (2015 and 2016)

2.4 Botulinum Neurotoxins Market Competitive Situation and Trends

2.4.1 Botulinum Neurotoxins Market Concentration Rate

2.4.2 Botulinum Neurotoxins Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Botulinum Neurotoxins Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Botulinum Neurotoxins Sales and Market Share by Type (2011-2016)

3.2 USA Botulinum Neurotoxins Revenue and Market Share by Type (2011-2016)

3.3 USA Botulinum Neurotoxins Price by Type (2011-2016)

3.4 USA Botulinum Neurotoxins Sales Growth Rate by Type (2011-2016)

4 USA Botulinum Neurotoxins Sales (Volume) by Application (2011-2016)

4.1 USA Botulinum Neurotoxins Sales and Market Share by Application (2011-2016)

4.2 USA Botulinum Neurotoxins Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Botulinum Neurotoxins Manufacturers Profiles/Analysis

5.1 Johnson & Johnson

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Botulinum Neurotoxins Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Johnson & Johnson Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 GSK

5.2.2 Botulinum Neurotoxins Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 GSK Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Allergan

5.3.2 Botulinum Neurotoxins Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Allergan Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Chong Kun Dang

5.4.2 Botulinum Neurotoxins Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Chong Kun Dang Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Eisai

5.5.2 Botulinum Neurotoxins Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Eisai Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Nestle

5.6.2 Botulinum Neurotoxins Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Nestle Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Galderma

5.7.2 Botulinum Neurotoxins Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Galderma Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Ipsen

5.8.2 Botulinum Neurotoxins Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Ipsen Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Hugel

5.9.2 Botulinum Neurotoxins Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Hugel Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Mentor

5.10.2 Botulinum Neurotoxins Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Mentor Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 CROMA

5.12 Alphaeon

5.13 OBI Pharma

5.14 Revance Therapeutics

5.15 Daewoong Pharmaceutical

5.16 Medy-Tox

5.17 EpiVax

5.18 Anterios

5.19 Escape Therapeutics

5.20 Lipella

5.21 Malvern Cosmeceutics

5.22 PharmaVital

5.23 Merz Pharma

5.24 Transdermal

5.25 Valeant Pharmaceuticals

5.26 CNBG

6 Botulinum Neurotoxins Manufacturing Cost Analysis

6.1 Botulinum Neurotoxins Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Botulinum Neurotoxins

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Botulinum Neurotoxins Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Botulinum Neurotoxins Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Botulinum Neurotoxins Market Forecast (2016-2021)

10.1 USA Botulinum Neurotoxins Sales, Revenue Forecast (2016-2021)

10.2 USA Botulinum Neurotoxins Sales Forecast by Type (2016-2021)

10.3 USA Botulinum Neurotoxins Sales Forecast by Application (2016-2021)

10.4 Botulinum Neurotoxins Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Botulinum Neurotoxins

Table Classification of Botulinum Neurotoxins

Figure USA Sales Market Share of Botulinum Neurotoxins by Type in 2015

Figure Botulinum Neurotoxins A (BoNT/A) Picture

Figure Botulinum Neurotoxins B (BoNT/B) Picture

Figure Botulinum Neurotoxins E (BoNT/E) Picture

Figure Botulinum Neurotoxins F (BoNT/F) Picture

Figure Botulinum Neurotoxins C (BoNT/C) Picture

Figure Botulinum Neurotoxins D (BoNT/D) Picture

Figure Botulinum Neurotoxins G (BoNT/G) Picture

Table Application of Botulinum Neurotoxins

Figure USA Sales Market Share of Botulinum Neurotoxins by Application in 2015

Figure Medical Uses Examples

Figure Cosmetics Examples

Figure USA Botulinum Neurotoxins Sales and Growth Rate (2011-2021)

Figure USA Botulinum Neurotoxins Revenue and Growth Rate (2011-2021)

Table USA Botulinum Neurotoxins Sales of Key Manufacturers (2015 and 2016)

Table USA Botulinum Neurotoxins Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Botulinum Neurotoxins Sales Share by Manufacturers

Figure 2016 Botulinum Neurotoxins Sales Share by Manufacturers

Table USA Botulinum Neurotoxins Revenue by Manufacturers (2015 and 2016)

Table USA Botulinum Neurotoxins Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Botulinum Neurotoxins Revenue Share by Manufacturers

Table 2016 USA Botulinum Neurotoxins Revenue Share by Manufacturers

Table USA Market Botulinum Neurotoxins Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Botulinum Neurotoxins Average Price of Key Manufacturers in 2015

Figure Botulinum Neurotoxins Market Share of Top 3 Manufacturers

Figure Botulinum Neurotoxins Market Share of Top 5 Manufacturers

Table USA Botulinum Neurotoxins Sales by Type (2011-2016)

Table USA Botulinum Neurotoxins Sales Share by Type (2011-2016)

Figure USA Botulinum Neurotoxins Sales Market Share by Type in 2015

Table USA Botulinum Neurotoxins Revenue and Market Share by Type (2011-2016)

Table USA Botulinum Neurotoxins Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Botulinum Neurotoxins by Type (2011-2016)

Table USA Botulinum Neurotoxins Price by Type (2011-2016)

Figure USA Botulinum Neurotoxins Sales Growth Rate by Type (2011-2016)

Table USA Botulinum Neurotoxins Sales by Application (2011-2016)

Table USA Botulinum Neurotoxins Sales Market Share by Application (2011-2016)

Figure USA Botulinum Neurotoxins Sales Market Share by Application in 2015

Table USA Botulinum Neurotoxins Sales Growth Rate by Application (2011-2016)

Figure USA Botulinum Neurotoxins Sales Growth Rate by Application (2011-2016)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Johnson & Johnson Botulinum Neurotoxins Sales Market Share (2011-2016)

Table GSK Basic Information List

Table GSK Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table GSK Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Allergan Basic Information List

Table Allergan Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Allergan Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Chong Kun Dang Basic Information List

Table Chong Kun Dang Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Chong Kun Dang Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Eisai Basic Information List

Table Eisai Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eisai Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Nestle Basic Information List

Table Nestle Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Nestle Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Galderma Basic Information List

Table Galderma Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Galderma Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Ipsen Basic Information List

Table Ipsen Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Ipsen Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Hugel Basic Information List

Table Hugel Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Hugel Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Mentor Basic Information List

Table Mentor Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Mentor Botulinum Neurotoxins Sales Market Share (2011-2016)

Table CROMA Basic Information List

Table CROMA Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table CROMA Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Alphaeon Basic Information List

Table Alphaeon Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Alphaeon Botulinum Neurotoxins Sales Market Share (2011-2016)

Table OBI Pharma Basic Information List

Table OBI Pharma Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table OBI Pharma Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Revance Therapeutics Basic Information List

Table Revance Therapeutics Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Revance Therapeutics Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Daewoong Pharmaceutical Basic Information List

Table Daewoong Pharmaceutical Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Daewoong Pharmaceutical Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Medy-Tox Basic Information List

Table Medy-Tox Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Medy-Tox Botulinum Neurotoxins Sales Market Share (2011-2016)

Table EpiVax Basic Information List

Table EpiVax Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table EpiVax Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Anterios Basic Information List

Table Anterios Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Anterios Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Escape Therapeutics Basic Information List

Table Escape Therapeutics Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Escape Therapeutics Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Lipella Basic Information List

Table Lipella Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Lipella Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Malvern Cosmeceutics Basic Information List

Table Malvern Cosmeceutics Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Malvern Cosmeceutics Botulinum Neurotoxins Sales Market Share (2011-2016)

Table PharmaVital Basic Information List

Table PharmaVital Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table PharmaVital Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Merz Pharma Basic Information List

Table Merz Pharma Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merz Pharma Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Transdermal Basic Information List

Table Transdermal Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Transdermal Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Valeant Pharmaceuticals Basic Information List

Table Valeant Pharmaceuticals Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table Valeant Pharmaceuticals Botulinum Neurotoxins Sales Market Share (2011-2016)

Table CNBG Basic Information List

Table CNBG Botulinum Neurotoxins Sales, Revenue, Price and Gross Margin (2011-2016)

Table CNBG Botulinum Neurotoxins Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Botulinum Neurotoxins

Figure Manufacturing Process Analysis of Botulinum Neurotoxins

Figure Botulinum Neurotoxins Industrial Chain Analysis

Table Raw Materials Sources of Botulinum Neurotoxins Major Manufacturers in 2015

Table Major Buyers of Botulinum Neurotoxins

Table Distributors/Traders List

Figure USA Botulinum Neurotoxins Production and Growth Rate Forecast (2016-2021)

Figure USA Botulinum Neurotoxins Revenue and Growth Rate Forecast (2016-2021)

Table USA Botulinum Neurotoxins Production Forecast by Type (2016-2021)

Table USA Botulinum Neurotoxins Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370